SUNNYVALE, Calif., Jan. 23 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO) will
announce it's fourth quarter and year-end 2000 financial results on Thursday,
February 8, 2001 before the market opening. The Company will conduct a
conference call on the same day at 7:00 am PT/ 10:00 am ET.
Conference call #: 888-850-2545
You can access a live broadcast of the call via the Internet at
http://www.sciosinc.com. The webcast will be archived on the website through
February 23.
A telephone replay of this conference call will be available until
February 15, 2001 at 4 pm PT.
Replay#: 888-203-1112
Confirmation code#: 422125
For further information, please contact Wendy Carhart, Associate Director
of Investor Relations and Corporate Communications at Scios Inc.
408-616-8325 or carhart@sciosinc.com
About Scios
Scios is a biopharmaceutical company developing novel treatments for heart
failure and rheumatoid arthritis. The company's disease-based technology
platform integrates expertise in protein biology with combinatorial and
medicinal chemistry to identify novel targets and rationally design large and
small-molecule compounds to treat cardiovascular and inflammatory diseases,
two of the world's leading unmet medical needs. Additional information on
Scios is available at http://www.sciosinc.com and in the company's various filings
with the Security and Exchange Commission.
SOURCE Scios Inc.
 back to top
Related links:
http://www.sciosinc.com
CONTACT:
Wendy Carhart of Scios Inc., 408-616 8325; or
Jim Weiss of WeissComm, 415-203 0328, for Scios, Inc.
|
